This fit well with the enhanced fungal burden observed for Nlrx1-deficient mice in our prior studies on day 1 and day 3 post challenge using three different models of IPA and one of immuno-competent challenge (6). The gene discussed is NLRX1; the disease is Ito hypomelanosis.